Prime Medicine Inc
NASDAQ:PRME 4:00:00 PM EDT
| Market Cap (Intraday) | 312.55M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.72 |
| 50-Day MA | $1.45 |
| 200-Day MA | $2.67 |
Prime Medicine Inc Stock, NASDAQ:PRME
60 First Street, Cambridge, Massachusetts 02141-2300
United States of America
Phone: +1.617.564.0013
Number of Employees: 214
Description
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.